Fox Jonathan C
SEC Form 4 insider trading activity
Fox Jonathan C has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, Fox Jonathan C is listed as Director at Edgewise Therapeutics, Inc. Inside the rolling window, Fox Jonathan C reported 1 open-market purchase totaling $199K in EWTX and no open-market sales.
Companies traded
Other insiders at EWTX
Insider Buying
$199K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fox Jonathan C made?
Fox Jonathan C has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Fox Jonathan C trade?
Fox Jonathan C has filed SEC Form 4 disclosures for 1 company, including EWTX.
When was Fox Jonathan C's most recent SEC Form 4 filing?
Fox Jonathan C's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is Fox Jonathan C's total buy and sell value in the current window?
Inside the rolling retention window, Fox Jonathan C bought $199K and sold $0 based on SEC Form 4 filings.
What was Fox Jonathan C's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,700 EWTX shares on 2025-11-11, worth $199K, per SEC Form 4 filings.